Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

Modern, Molecularly Informed Therapy for Patients With Advanced Endometrial CancerПодробнее

Sequencing PARP Inhibitors in Advanced Ovarian CancerПодробнее

Overcoming resistance to PARP inhibition in ovarian cancerПодробнее

PARP inhibitors and ovarian cancerПодробнее

New Treatment Approaches for Ovarian Cancer PARP inhibitors HIPEC and ImmunotherapyПодробнее

UROwebinar: PARP inhibitors in prostate cancer Part 2Подробнее

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP InhibitorsПодробнее

Precision Medicine in Ovarian Cancer With PARP Inhibitor Therapy and Companion DiagnosticsПодробнее

Upgrading the Treatment Algorithm for Advanced Ovarian CancerПодробнее

Enhancing Personalized Medicine in Ovarian Cancer: Advances in PARP Inhibition and Novel ModalitiesПодробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

Novel Therapies for Newly Diagnosed Advanced Ovarian CancerПодробнее

Using Novel Therapies in Advanced Ovarian CancerПодробнее

PARP Inhibitors and Ovarian Cancer | Memorial Sloan KetteringПодробнее

The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian CancerПодробнее

PARP inhibitors for ovarian cancerПодробнее

Standard of care and progress with PARP inhibitors for ovarian cancerПодробнее

PARP Inhibitors: Assessing the Rapidly Evolving Treatment LandscapeПодробнее

PARP Inhibitors in Advanced Ovarian CancerПодробнее

PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian CancerПодробнее

PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry GeneticsПодробнее